Development and Validation of a Screening Questionnaire for Psoriatic Arthritis



Similar documents
GENETIC ANALYSIS OF PSORIASIS AND PSORIATIC ARTHRITIS Department of Dermatology, University of Michigan

Psoriatic arthritis in practice : How to detect? How to diagnose? Pascal RICHETTE Hôpital Lariboisière, Paris. Copyright

It is worth noting that people with psoriasis can also develop other forms of arthritis such as rheumatoid arthritis and osteoarthritis.

Understanding Rheumatoid Arthritis

Psoriasis, Incidence, Quality of Life, Psoriatic Arthritis, Prevalence

Psoriatic Arthritis

University of Toronto Psoriatic Arthritis Program

PRACTICAL HELP FROM THE ARTHRITIS FOUNDATION Psoriatic Arthritis

(Intro to Arthritis with a. Arthritis) Manager of Education & Services for the Vancouver Island Region of The Arthritis Society

Psoriatic arthritis FACTSHEET

Psoriatic Arthritis. What is psoriatic arthritis? Understanding joints. Who gets psoriatic arthritis? Page 1 of 5

my personal joint profile Your own personal profile of how rheumatoid arthritis is affecting your joints.

A patient guide to psoriasis/ psoriatic arthritis URAC. All Walgreens specialty pharmacy locations are ACHC and URAC accredited.

7 th Annual Congress of Iran Rheumatology Association (IRA)

Psoriasis Can be Cured with Homoeopathy

Medicines for Psoriatic Arthritis. A Review of the Research for Adults

Do I need a physician referral? Yes, we see patients on referral from a health care provider.

Doctor Discussion Guide for Osteoarthritis

Stickler Syndrome and Arthritis

History and Physical Examination for Rheumatic Disease for MUSC Students

Summary of the risk management plan (RMP) for Otezla (apremilast)

teaching hospital and research centre, Himayath sagar road, Hyderabad, Telangana state, India 2

NURS 821 Alterations in the Musculoskeletal System. Rheumatoid Arthritis. Type III Hypersensitivity Response

Psoriatic Arthritis. Ewa Olech, MD Division of Rheumatology University of Nevada School of Medicine Las Vegas

Arthritis

Early identification and treatment - the Norwegian perspective. Till Uhlig Dept of Rheumatology Diakonhjemmet Hospital Oslo, Norway

Profile of Psoriatic Arthritis: What to expect as a typical patient Dr Deepak Jadon

Autoimmune Diseases More common than you think Randall Stevens, MD

DIVISION OF RHEUMATOLOGY DEPARTMENT OF MEDICINE UNIVERSITY OF WESTERN ONTARIO POSTGRADUATE EDUCTION ORTHOPAEDIC OFF-SERVICE GOALS & OBJECTIVES

Latvian Early Intervention Concept development

Psoriatic Arthritis Current Guidelines. Linda Sekhon, DHSc, PA-C

Updating Rheumatology Skills in Primary Care: The Maine Arthritis Partnership (MAP) Program

Nail Psoriasis. A positive approach. to psoriasis and. psoriatic arthritis

X-Plain Psoriasis Reference Summary

Rheumatic Diseases, Psoriasis, and Crohn s Disease

Condition Psoriatic arthritis. Psoriatic arthritis. This booklet provides information and answers to your questions about this condition.

Early Diagnosis of Rheumatoid Arthritis & Axial Spondyloarthritis

DIFFERENTIATING INFLAMMATORY AND MECHANICAL BACK PAIN

Predictors of Physical Therapy Use in Patients with Rheumatoid Arthritis

What is Psoriasis? Common Areas Affected. Type Who Does it Affect Characteristics

Exploring Care for Psoriatic Arthritis: Bridging Dermatology and Rheumatology

Psoriatic Arthritis. Title. Understanding and Managing. in All the Wrong Places. Clinical Features. Etiology of Psoriatic Arthritis

Rheumatology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Rheumatology

Psoriatic Arthritis KNOW YOUR OPTIONS

Dr Sarah Levy Consultant Rheumatology Croydon University Hospital

Arthritis: An Overview. Michael McKee, MD, MPH February 23, 2012

A User's Guide to: Rheumatoid and Arthritis Outcome Score RAOS

Methotrexate Is Not Disease Modifying In Psoriatic Arthritis

2010 ACR/EULAR Classification Criteria for Rheumatoid Arthritis

Modifiers 25 and 59. Modifier 25

University of Toronto Psoriatic Arthritis Program

Arthritis and Rheumatology Clinics of Kansas Patient Education. Reactive Arthritis (ReA) / Inflammatory Bowel Disease (IBD) Arthritis

Shared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)

Biologic Treatments for Rheumatoid Arthritis

Psoriasis Treatment Transition Pathway

Treating psoriasis and psoriatic arthritis. A booklet for patients and carers

M05.9 Rheumatoid arthritis with rheumatoid factor, unspecified M06.00 Rheumatoid arthritis without rheumatoid factor, unspecified site M06.

Information on Rheumatoid Arthritis

Additional details >>> HERE <<<

RHEUMATOID ARTHRITIS. Dr Bruce Kirkham Rheumatology Clinical Lead

Is Monotherapy Treatment of Etanercept Effective Against Plaque Psoriasis?

Instrument: Nail Assessment in Psoriasis and Psoriatic Arthritis

Electronic Medical Records

Atlantis Physical Therapy Associates

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT

How To Choose A Biologic Drug

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Overview of Rheumatology

PATIENT REGISTRATION

Psoriatic Arthritis: a Critical Review

PREVALENCE OF ARTHRITIS AND RHEUMATIC DISEASES AROUND THE WORLD A Growing Burden and Implications for Health Care Needs

Rheumatoid Arthritis

Evaluation of a Self- Management Course Using the Health Education Impact Questionnaire

Transcription:

Development and Validation of a Screening Questionnaire for Psoriatic Arthritis Dafna D. Gladman 1, Catherine T. Schentag 1, Brian D. Tom 2, Vinod Chandran 1, Cheryl F. Rosen 1 Vernon T. Farewell 2 1 University of Toronto, Canada and 2 MRC Biostatistics Unit, Cambridge, UK Toronto Western Hospital

questionnaire (ToPAS) The CASPAR criteria for the classification of PsA should be helpful in diagnosing the disease High sensitivity and specificity in early PsA» Chandran V, et al. Arthritis Rheum 2006:54(S9):S717 High sensitivity and specificity in family medicine» Chandran V, et al Arthritis Rheum 2006:54: 4091 However, an assessment by a physician to document inflammatory arthritis is necessary

In certain clinical and epidemiological settings it is impossible to have all patients reviewed by a physician Therefore, a screening tool to identify patients who may have PsA is necessary

Objective To develop and validate a screening questionnaire to identify patients with a high likelihood of having PsA for use in clinical settings and epidemiological studies

Methods Development of ToPAS Review of symptoms and signs seen among patients with PsA Evaluation of the questionnaire by:» Patients with PsA» Patients attending a rheumatology clinic» Rheumatologists, dermatologists, epidemiologists, scientists

The Psoriatic Arthritis Clinic, Centre for Prognosis Studies in The Rheumataic Diseases Toronto Western Hospital, University Health Network, University of Toronto July 1999 Study # Toronto Psoriatic Arthritis Screening Questionnaire Date: / / yr mo da Please tick () each correct response or fill in the blank for all questions on both sides of the page Date of Birth : / / Gender o Male yr mo da o Female Ethnic Background: Figure 1 Skin rash on the elbows Figure 2 Pits in the nail Figure 3 Lifting of the nail 1a. Have you ever had a skin rash consisting of red AND silvery-white scaly areas particularly on the elbows, knees or scalp as shown in FIGURE 1? If YES b. At approximately what age did you first notice this skin rash? c. Do you have this rash now? 2. Have you ever noticed any of these changes in your fingernails a. Pits in the nails as shown in figure 2 b. Lifting of the nail from the nail bed as shown in figure 3? If YES a. At approximately what age did you first notice them? b. Do you have either of these nail changes now? 3. Have you ever seen a doctor about a skin rash? 4. Has a doctor ever diagnosed you with psoriasis? If YES a. At approximately what age did you first notice this skin rash? years old years old years old

5a. Have you ever had joint pain, joint stiffness or swollen red joints that was not the results of Injury? If YES a. At approximately what age did you first notice these symptoms? b. Do you have any symptoms now? 6. Have you ever had a sausage shaped swollen finger or toe that was not the result of an injury? 7. Have you ever had neck pain lasting at least 3 months that was not injury related? If YES a. Was the neck pain accompanied by stiffness? b. Do you have any neck pain now? 8. Have you ever had back pain lasting at least 3 months that was not injury related? If YES a. Was the back pain accompanied by stiffness? b. Do you have any back pain now? 9. Have you ever had a skin rash on any part of your body at the same time as joint pain, joint stiffness or swollen red joints? If YES a. At approximately what age did you first notice this skin rash? b. Do you have this rash now? 10. Have your ever seen a doctor about any joint pain? 11. Have you ever been diagnosed with any form of arthritis other than psoriatic arthritis? Rheumatoid arthritis Osteoarthritis Lupus (SLE) Fibromyalgia Ankylosing spondylitis Scleroderrma Other 12. Has a doctor ever diagnosed you with psoriatic arthritis? If Yes a. At what age were your first diagnosed? years old years old O O O O O O O years old

Testing ToPAS Methods ToPAS was administered to consecutive consenting patients attending 5 different clinics: 1. The University of Toronto PsA clinic 2. A psoriasis phototherapy centre 3. A general dermatology clinic 4. A general rheumatology clinic (excluding PsA patients) 5. A family medicine clinic

Confirming the diagnosis of PsA Patients who completed ToPAS were assessed by a rheumatologist» Standard protocol Methods» Complete history, physical examination, and where appropriate, radiographic assessment. Based on the protocol the rheumatologist diagnosed a patient with PsA if they had an inflammatory arthritis in the presence of psoriasis CASPAR criteria were applied

Methods: statistical analysis A three-step analysis strategy was adopted 1. A stepwise logistic regression to identify a model with the questions considered to be most important in discriminating between those who were diagnosed with PsA and those who were not 2. A logistic model was fitted to three clinically relevant domains for identifying PsA suggested from step 1: the skin, joints, and nails 3. A simple weighting of each of the domains used in step 2 was considered.» ROC curves obtained at each step

Results Group PsA clinic Psoriasis clinic Dermatology Rheumatology Family medicine Total 134 123 118 135 178 PsA Dx (%) 134 (100) 39 (24.4) 2 ( 1.7) 0 ( 0) 3 ( 1.7)

Logistic regression model from backward stepwise selection Estimate Standard error P value Intercept Skin rash Pits Diagnosed Ps Joint pain Sausage digit Back pain Seen MD Other Dx -8.56 1.02 0.84 O 2.53 3.05 1.89 0.77 2.34-1.36 1.08 0.54 0.43 0.54 0.94 0.40 0.41 0.70 0.43 <0.0001 0.060 0.051 <0.0001 0.001 <0.0001 0.060 0.001 0.002 Residual variance (df) AIC 572.73 (469) 192.62

ROC Curve for initial logistic regression model Sensitivity 0.0 0.2 0.4 0.6 0.8 1.0 Cut point 7.71 Sens: 94.2% Spec: 91.5% PV+: 81.6% PV-: 97.5% AUC: 0.973 0.0 0.2 0.4 0.6 0.8 1.0 1-Specificity

Logistic regression model for the domain variables Variable Skin Domain Joint Domain Nail Domain Definition Skin rash + Seen doctor about skin rash + Psoriasis Dx (Count of yes answers: Range 0-3) Joint pain + Sausage digit + Seen doctor about joint pain (Count of yes answers: Range 0-3) Pits in nails or Lifting of nail (Yes or no: Yes =1, No = 0) Neck and back pain questions did not improve model (p = 0.46)

ROC Curve based on Domains Sensitivity 0.0 0.2 0.4 0.6 0.8 1.0 Cut point 7.76 Sens: 90.3% Spec: 90.5% PV+: 78.9% PV-: 96.2% AUC: 0.954 0.0 0.2 0.4 0.6 0.8 1.0 1-Specificity

Simplified weighting based on logistic regression Joints = 2, Skin = 1, Nail = 1 Discriminatory score: 2x (Joint domain variable) + 1x (Skin domain variable) + 1x (Nail domain variable)

ROC Curve based on Simplified Domains Sensitivity 0.0 0.2 0.4 0.6 0.8 1.0 Cutpoint 8 Sens: 86.8% Spec: 93.1% PV+: 83.0% PV-: 94.8% AUC: 0.954 0.0 0.2 0.4 0.6 0.8 1.0 1-Specificity

Sensitivity and specificity of ToPAS Patient groups* Psoriasis Dermatology Rheumatology Family medicine * Each grouped with PsA Sensitivity (95% CI) 89.1% (89.1, 93.2) 91.9% (85,7, 95.6) 92.6% (86.4, 96.1) 90.4% (83.9, 94.5) Specificity (95% CI) 86.3% (76.4, 92.5) 95.2% (88.0, 98.2) 85.7% (76.9, 91.5) 100%

Summary ToPAS was derived from features of PsA and input from patients and investigators ToPAS is simple, only 12 questions The simplified index derived ToPAS proved highly sensitive and specific in 4 groups of patients Psoriasis General dermatology General rheumatology Family medicine

Our simplified index derived from the ToPAS is very good at identifying those who are diagnosed with PsA and those who are not This instrument is now ready for further validation It should be tested in other centers to confirm its usefulness in screening for PsA It should be tested in family investigations

Acknowledgements Contribution of all the patients Support from: TAS CIHR ACE (UHN) CPSRD Toronto Western Hospital Krembil Foundation